Document is current

Article History

First Online: 21 May 2020

Compliance with Ethical Standards

:

: Claire Wilson has no conflicts of interest that are directly relevant to the content of this article. Vivian Y. Shi, MD is a stock shareholder of Dermveda, has served as an advisor for Sanofi Genzyme/Regeneron, Abbvie, Novartis, SUN Pharma, Pfizer, Menlo Therapeutics, Burt’s Bees, GpSkin, the National Eczema Association, and Global Parents for Eczema Research, is an investigator for AbbVie, Regeneron, Novartis, and LEO Pharma, and has received research funding from the Foundation for Atopic Dermatitis and Skin Actives Scientific. There were no incentives or transactions financial or otherwise, relevant to this manuscript. Joanna Jaros has no relevant conflicts of interest to disclose. She is a consultant for obVus solutions, LLC (a fitness tracker) and a content editor for the blogs/websites: “The Eczema Company” and “It’s an Itchy Little World.”